Financial Astrology of Pfizer Inc.

FINANCIAL ASTROLOGY

First Trade Date for Pfizer Inc.

Company Name	First Trade Date (yyyy-mm-dd)
Pfizer Inc.	1944-01-17

Company Name	Symbol
Pfizer Inc.	PFE
History and Business of Company (this information may include date of incorporation)
Pfizer Inc. (which may be referred to as Pfizer, the Company, we, us or our) is a research-based, global pharmaceutical company. We discover, develop, manufacture and market leading prescription medicines for humans and animals as well as many of the world's best-known consumer healthcare products. The Company was incorporated under the laws of the State of Delaware on June 2, 1942. We acquired Warner-Lambert Company (Warner-Lambert) on June 19, 2000. The acquisition was accounted for as a pooling of interests. In accordance with generally accepted accounting principles in the U.S. (GAAP), we restated all consolidated financial statements of Pfizer for periods prior to the acquisition to include the results of operations and financial position of Warner-Lambert as if we had always been merged. We acquired Pharmacia Corporation (Pharmacia) on April 16, 2003. The acquisition was accounted for as a purchase. In accordance with GAAP, we did not restate our results of operations and financial position to reflect the historical results of operations and financial position of Pharmacia. We completed the acquisition of Esperion Therapeutics, Inc. on February 10, 2004, for $1.3 billion in cash. The acquisition is being accounted for as a purchase. Esperion is a biopharmaceutical company focused on the development of high density lipoprotein (HDL)-targeted ("good cholesterol") therapies for the treatment of cardiovascular disease. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 are available on our website (www.pfizer.com under the "Who We Are - For Investors - SEC Filings by Pfizer" captions) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (SEC). Throughout this 2003 Form 10-K, we "incorporate by reference" certain information from parts of other documents filed with the SEC, including our Annual Report to Shareholders for 2003 and our proxy statement for the 2004 Annual Meeting of Shareholders. The SEC allows us to disclose important information by referring to it in that manner. Please refer to such information. This year, our Annual Report to Shareholders consists of two booklets: the 2003 Annual Review (2003 Annual Review) and the 2003 Financial Report (2003 Financial Report). Portions of our 2003 Financial Report are filed as exhibit 13 to this 2003 Form 10-K. On or about March 12, 2004, our 2003 Annual Review, 2003 Financial Report and proxy statement for the 2004 Annual Meeting of Shareholders will be available on our website (www.pfizer.com); the 2003 Annual Review and 2003 Financial Report will be set forth under the "Who We Are - For Investors - Financial Reports" captions, and the proxy statement will be set forth under the "Who We Are - For Investors - SEC Filings by Pfizer" captions. Information relating to corporate governance at Pfizer, including our Corporate Governance Principles; Director Qualification Standards; Chief Executive Officer and Chief Financial Officer certifications; Standards of Business Ethics and Conduct for all of our employees, including our Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer; Code of Business Conduct and Ethics for our Directors; and information concerning our Directors, e-mail communication with our Directors, Board Committees, including Committee charters, and transactions in Pfizer securities by Directors and officers, is available on our website at www.pfizer.com under the "Who We Are - For Investors - Corporate Governance" captions. We will provide any of the foregoing information without charge upon written request to Margaret M. Foran, Vice President-Corporate Governance and Secretary, Pfizer Inc., 235 East 42nd Street, New York, NY 10017-5755. Information relating to shareholder services, including our Shareholder Investment Program, book-entry share ownership and direct deposit of dividends, is available on our website at www.pfizer.com under the "Who We Are - For Investors - Shareholder Services" captions.

IMPORTANT DISCLAIMER: By reading any of the material on this website you agree to our DISCLAIMER: The Magi Society, Magi Astrologers Worldwide Corporation make no claims whatsoever concerning the validity of the information provided herein, and will not be held liable for any use thereof. No information or opinion expressed here is a solicitation to buy or sell securities, bonds, real estate, commodities, options, futures or any financial instruments whatsoever.